MoonLake Immunotherapeutics (MLTX) insider trading
Every open-market stock purchase and sale by MoonLake Immunotherapeutics executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $77.8M over the last 12 months (10 sales).
- Last insider buy: Matthias Bodenstedt (CFO), $98.8K, 12 months ago.
Last 12 months: insiders bought $98.8K (1 buy) and sold $77.8M (10 sales). Last close $17.90 on Jun 4, 2026.
Recent MLTX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 22, 2026 | Matthias Bodenstedt (CFO) | Sold | $862K |
| Jun 18, 2026 | Matthias Bodenstedt (CFO) | Sold | $54.8K |
| Jun 17, 2026 | Kristian Reich (C-suite exec) | Sold | $972K |
| Jun 17, 2026 | Matthias Bodenstedt (CFO) | Sold | $297K |
| Jun 17, 2026 | Catherine Moukheibir (Director) | Bought (not open market) | — |
| Jun 17, 2026 | Spike Loy (Director) | Bought (not open market) | — |
| Jun 17, 2026 | Ramnik Xavier (Director) | Bought (not open market) | — |
| Jun 17, 2026 | Andrew John Phillips (Director) | Bought (not open market) | — |
| Jun 17, 2026 | Bvf Partners L P/il (10% owner) | Bought (not open market) | — |
| Jun 16, 2026 | Kristian Reich (C-suite exec) | Sold | $935K |
| Jun 15, 2026 | Kristian Reich (C-suite exec) | Sold | $945K |
| May 11, 2026 | Matthias Bodenstedt (CFO) | Sold | $273K |
| Apr 14, 2026 | Matthias Bodenstedt (CFO) | Sold | $47.5K |
| Apr 13, 2026 | da Silva Jorge Santos (CEO) | Sold | $946K |
| Apr 10, 2026 | da Silva Jorge Santos (CEO) | Sold | $1.8M |
| Apr 10, 2026 | Matthias Bodenstedt (CFO) | Sold | $37.6K |
| Apr 9, 2026 | Matthias Bodenstedt (CFO) | Sold | $1.6M |
| Mar 31, 2026 | Bvf Partners L P/il (10% owner) | Sold | $32.4M |
| Mar 31, 2026 | Bvf Partners L P/il (10% owner) | Sold | $26.3M |
| Mar 31, 2026 | Bvf Partners L P/il (10% owner) | Sold | $4.2M |
| Jan 7, 2026 | Kristian Reich (C-suite exec) | Bought (not open market) | — |
| Jan 7, 2026 | da Silva Jorge Santos (CEO) | Bought (not open market) | — |
| Jan 7, 2026 | Matthias Bodenstedt (CFO) | Bought (not open market) | — |
| Dec 19, 2025 | Kristian Reich (C-suite exec) | Sold (not open market) | — |
| Dec 19, 2025 | Kristian Reich (C-suite exec) | Bought (not open market) | — |
Who's trading MLTX
- Matthias Bodenstedt, CFO: bought $98.8K (1 buy), sold $3.2M (7 sales), last Jun 22, 2026
- Ramnik Xavier, Director: other filings, last Jun 17, 2026
- Andrew John Phillips, Director: other filings, last Jun 17, 2026
- Kristian Reich, C-suite exec: sold $5.9M (5 sales), last Jun 17, 2026
- Bvf Partners L P/il, 10% owner: sold $63M (3 sales), last Jun 17, 2026
- Spike Loy, Director: other filings, last Jun 17, 2026
- Catherine Moukheibir, Director: other filings, last Jun 17, 2026
- da Silva Jorge Santos, CEO: sold $5.7M (4 sales), last Apr 13, 2026
Get free alerts when an insider at MoonLake Immunotherapeutics files a new trade →